Diagnosis And Intervention Of Metabolic Syndrome

Metabolic syndrome is a pathological condition of various abnormal component aggregation. Since1988, people have a preliminary understanding about MS. Diagnostic criteria in this20years MS undergoes many changes and no one recognized around the world as the standard. This makes MS research brings a lot of difficulties. Until in2009the International Diabetes Federation (IDF), American Heart Association (AHA), the national heart, lung and Blood Institute (NHLBI), the World Heart Federation (WHF), International Atherosclerosis Society (IAS) and many other organizations formed a joint standard. Currently the study thank that the MS diagnosis should include:triglyceride (TG), fasting blood glucose (FPG), high density lipoprotein cholesterol (HDL-C), blood pressure (BP), waist circumference (waist circumference, WC) or body mass index (Body Mass Index BMI),and other abnormal index.The incidence of MS can not be ignored. Although the diagnostic criteria used in various regions are not the same, as early as2000the United States have reported, about47000000Americans with MS. Chinese Diabetes Society (CDS) diagnostic criteria now is the most used in our country. According to our country in recent years the incidence of MS is reported, by calculation of China’s MS patients has reached more than200000000, except in the elderly with high incidence trend. And in the incidence of teenage MS rates are also on the rise.Lifestyle has obvious influence on MS. High fat and high calorie diet, can lead to obesity. Obesity and insulin resistance are closely linked, which leads to the high incidence of MS. The lifestyle intervention to improve the sedentary lifestyle, adjust dietary structure reasonable to reduce weight, improve insulin resistance, is very effective for all patients with MS.In the aspect of medical treatment of MS while there is no cure, but drugs recommended by IDF for the different composition anomalies in the corresponding treatment, but treatment can reduce the risk of patients with MS factor.